Archive for avril, 2009

I decided to waste some time this evening checking out twitter statistics on twanalyst for my favorite corporate pharma twitter accounts: Boehringer, Novartis, JNJComm, Roche and AstraZenecaUS. As I pointed out in my previous post: Pharma and twitter these companies have dared to take the jump into this new microblogging thing fairly recently - so [...]

Patientslikeme announced last week: “ a pilot program in our multiple sclerosis community which helps patients submit treatment-related adverse events directly to the The U.S. Food and Drug Administration (FDA) through our site“.
This got me wondering: what will the impact be on adverse event reporting overall?  how much of an increase in total adverse events [...]

I just came across the MyMSmyway site. This site provides technology solutions to people with MS to help them with the challenges to their vision, cognition or dexterity that MS can create. It was created out of a collaboration between Bayer Healthcare, Microsoft and the National MS society and originated from a survey of 2,390 [...]


About this blog

The Internet holds the power to profoundly change the way healthcare is delivered. Millions of patients, caregivers and physicians turn to the Internet every day to look up the latest information on important health topics and find support from like-minded people.

Continue reading...

  • Kwai Yu: Hi Silja, Cherie sent me a quick note about you ... no wonder she said you were amazing :-) I [...]
  • Evaluating Pharmaceutical Twitter Accounts | PRforPharma: [...] compare to so-called best practices for Twitter engagement.  WhyDotPharma has already conduct [...]
  • Tammy: I enjoyed your posting. Especially the part about the, BOGSAT’s syndrom: Bunch Of Guys Sitting Aro [...]
  • Sabine: Hi Silja, my guess is: about 5 Mio Very interesting and helpful findings there - curious to se [...]
  • R.J. Lewis: Nice analysis! Nice to see someone is tracking pharma's activity. Perhaps you should set up an ann [...]

whydotpharma